recurrent venous thromboembolism

Related by string. * Recurrent : Recurrent Pattern Detection RPD . recurrent urinary tract infections . recurrent ovarian cancer / Venous : intra venous . venous stasis ulcers . Venous stasis ulcers / Thromboembolism . thromboembolisms . thrombo embolism : venous thromboembolism VTE prophylaxis . venous thromboembolism prophylaxis . venous thromboembolism VTE * *

Related by context. All words. (Click for frequent words.) 76 recurrent VTE 76 postoperative AF 76 reinfarction 74 colorectal adenoma 74 symptomatic VTE 74 Febrile neutropenia 73 rebleeding 73 nonfatal MI 72 venous thromboembolic disease 72 endometrial hyperplasia 72 thrombotic complications 72 hemorrhagic complications 72 nonvertebral fractures 72 polyp recurrence 72 severe exacerbations 72 nonfatal myocardial infarction MI 71 nonfatal stroke 71 Hypotension 71 recurrent DVT 71 venous blood clots 71 arterial thromboembolic events 71 PRADAXA #mg 71 Erythropoietic therapies may 71 perioperative mortality 71 thromboembolism 71 macrovascular events 70 morphometric vertebral fractures 70 glycated hemoglobin levels 70 neutrophil counts 70 CVD mortality 70 upper gastrointestinal bleeding 70 prolonged QT interval 70 deep venous thromboses 70 intracerebral haemorrhage 70 cerebrovascular events 70 thromboembolic 70 symptomatic intracranial 70 postoperative infections 70 dysglycemia 70 leucopenia 70 carotid atherosclerosis 70 histologic subtype 70 TEAEs 69 recurrent myocardial infarction 69 periprocedural 69 β blockers 69 thromboembolic complications 69 CP CPPS 69 invasive aspergillosis 69 coronary stenosis 69 nadroparin 69 noncardiac 69 ximelagatran 69 neurodevelopmental impairment 69 postoperative delirium 69 recurrent ischemia 69 pyridostigmine 69 thromboembolic disease 69 postoperative atrial fibrillation 69 NNT = 69 HIV HCV coinfected 69 genital herpes infections 69 Myocardial infarction 69 serum homocysteine 69 relapsed MM 68 haematological toxicity 68 haematologic 68 variceal bleeding 68 chronic periodontitis 68 corrected QT interval 68 VTEs 68 external genital lesions 68 Thromboembolism 68 % CI #.#-#.# [008] 68 beta carotene supplementation 68 bronchopulmonary dysplasia 68 embolic stroke 68 advanced adenoma 68 confidence interval #.#-#.# 68 thrombocytopenic 68 Severe hypoglycemia 68 inhaled budesonide 68 perioperatively 68 venous thromboembolic events 68 thromboembolic events 68 neurologic complications 68 LV dysfunction 68 carotid stenosis 68 leiomyomas 68 intraoperative complications 68 hepatorenal syndrome 68 hematologic toxicity 68 renal scarring 68 refractory ischemia 68 intravenous bisphosphonates 68 torsade de pointes 68 acute GVHD 68 CMV infection 68 proximal DVT 68 androgen suppression 68 postoperative morbidity 68 ALT elevation 68 postoperative complications 68 TMP SMX 68 haemorrhagic strokes 68 contrast induced nephropathy 68 % CI #.#-#.# [003] 68 ALT flares 68 beta blocker therapy 67 ipsilateral stroke 67 gastrointestinal perforation 67 serum estradiol 67 NATRECOR ® 67 flutamide 67 intima media thickness 67 atherogenic dyslipidemia 67 symptomatic intracranial hemorrhage 67 intravascular hemolysis 67 Heavy menstrual bleeding 67 transaminase elevations 67 QTc prolongation 67 clodronate 67 platelet clumping 67 CYP#D# inhibitor 67 anticoagulant warfarin 67 CR nPR 67 urolithiasis 67 nondiabetic patients 67 invasive candidiasis 67 glomerular filtration 67 pulmonary dysfunction 67 hypercholesterolaemia 67 colorectal adenomas 67 p = #.# [003] 67 ertapenem 67 bezafibrate 67 nonvertebral fracture 67 thrombotic events 67 variant angina 67 NIH CPSI 67 perioperative complications 67 pulmonary toxicity 67 EXJADE 67 hypoglycemic episodes 67 locoregional recurrence 67 adenoma recurrence 67 FluCAM arm 67 % CI #.#-#.# [004] 67 neurodevelopmental outcome 67 anastomotic leak 67 venous thromboembolisms 67 candidemia 67 octreotide LAR 67 intracranial hemorrhage ICH 67 confidence interval CI 67 adjunctive placebo 67 salmeterol HFA MDI 67 postoperative complication 67 COPD exacerbation 67 oxycodone CR 67 DVT PE 67 nonmelanoma skin cancers 67 PLX STROKE targeting 67 overt hepatic encephalopathy HE 67 HER2 expression 67 serum parathyroid hormone 67 postoperative mortality 67 PASI scores 67 NATRECOR R 67 platelet reactivity 67 hyperbilirubinemia 67 antioxidant supplementation 67 conjugated estrogen 67 neurologic sequelae 67 haemorrhagic stroke 67 chronic prostatitis 67 GI bleeds 67 antibody titer 67 prostate cancer CaP 67 pCR 67 serum calcium 67 thiazide diuretics 67 ruptured aneurysms 67 depressive symptomatology 66 antiplatelet drugs 66 histological subtype 66 serum aminotransferase levels 66 arterial calcification 66 cirrhotic patients 66 diastolic hypertension 66 postpartum hemorrhage 66 colorectal neoplasms 66 Helicobacter pylori eradication 66 PRADAXA 66 platelet activation 66 symptomatic pulmonary embolism 66 transfusion syndrome 66 testicular tumors 66 androgen ablation 66 tamoxifen Nolvadex ® 66 hypoglycaemic episodes 66 HbA 1c levels 66 cerebral vasospasm 66 hypoglycemic events 66 hypercalciuria 66 probiotic supplementation 66 sotalol 66 #.#/#.# mmHg [001] 66 elevated ALT 66 carotid plaques 66 extrapyramidal symptoms 66 recurrent atrial fibrillation 66 asthma exacerbations 66 hemodilution 66 dysmenorrhoea 66 elevated IOP 66 H. pylori eradication 66 recurrent UTI 66 hypocalcaemia 66 nonischemic 66 Renal dysfunction 66 atrophic gastritis 66 cilostazol 66 hyperacute 66 myocardial fibrosis 66 severe asthma exacerbations 66 serum urate levels 66 onset diabetes mellitus 66 antithrombotic therapy 66 racemic albuterol 66 lichen planus 66 ischemic lesions 66 atherothrombotic 66 cardiovascular hospitalizations 66 % Confidence Interval 66 analgesic medications 66 bacteriuria 66 FRAGMIN 66 adrenal suppression 66 oral prednisolone 66 plasma triglycerides 66 arterial occlusion 66 SGPT 66 allogeneic HSCT 66 dyslipidaemia 66 corticosteroid therapy 66 atherothrombotic events 66 chlamydial infection 66 salmeterol fluticasone 66 idraparinux 66 hyperhomocysteinemia 66 syncopal 66 Pulmonary embolism 66 endometrial thickness 66 ocular toxicity 66 cobiprostone 66 endometrial carcinoma 66 anemia hemoglobin 66 definite stent thrombosis 66 Infusion Reactions Severe 66 acute myocardial infarctions 66 myopathy rhabdomyolysis 66 overt nephropathy 66 Stent thrombosis 66 hip BMD 66 receiving XGEVA 66 MACCE 66 opioid overdose 66 Postoperative complications 66 leukocyte count 66 inhospital 66 cervical intraepithelial neoplasia 66 IOP lowering 66 severe rotavirus gastroenteritis 66 haloperidol Haldol 66 prednisone prednisolone 66 aldosterone antagonist 66 COPD exacerbations 66 thrombo embolic 66 psychiatric comorbidities 66 abnormal lipid 66 antiplatelet medications 66 GnRH agonist 66 alanine aminotransferase 65 arterial thickening 65 pretreatment serum 65 direct thrombin inhibitors 65 aneurysmal subarachnoid hemorrhage 65 Adjuvant chemotherapy 65 parkinsonian symptoms 65 HF hospitalization 65 SUVmax 65 thromboprophylaxis 65 periprocedural MI 65 atherothrombotic disease 65 myocardial reperfusion 65 KRAS mutations occur 65 nocturnal hypoglycemia 65 cardioembolic stroke 65 triacylglycerol concentrations 65 spontaneous preterm birth 65 caspofungin 65 haematuria 65 Avandia Actos 65 neutropenic fever 65 dentinal hypersensitivity 65 S. aureus colonization 65 serum cortisol 65 glycosylated hemoglobin HbA1c 65 CHD mortality 65 LNG IUS 65 thyrotropin levels 65 subclinical hypothyroidism 65 alteplase 65 thromboses 65 QT interval prolongation 65 cancerdefine 65 nitroprusside 65 cerebral oxygenation 65 lupus anticoagulant 65 APTIVUS r 65 complement inhibitor eculizumab 65 systolic hypertension 65 Intussusception 65 untreated OSA 65 noncardiovascular 65 hemoptysis 65 systemic corticosteroid 65 hepatic cirrhosis 65 nephrotoxicity 65 thyrotropin 65 Toxicities 65 multivariable adjusted 65 venous thrombosis 65 laboratory abnormalities 65 NSAID induced 65 VT VF 65 prostate cancer PCa 65 elevated triglyceride levels 65 advanced adenomas 65 CDI recurrence 65 oesophageal adenocarcinoma 65 cranial irradiation 65 nocturnal hypoglycaemia 65 cardiac dysfunction 65 Calcium intake 65 salivary cortisol 65 Chlamydia trachomatis infection 65 myocardial infarctions MIs 65 aspartate aminotransferase 65 Venous thromboembolism 65 artery stenosis 65 nonfatal myocardial infarction 65 recurrent glioblastoma multiforme 65 macroalbuminuria 65 ventricular tachyarrhythmia 65 HeFH 65 reactogenicity 65 aminotransferases 65 renal toxicity 65 STRIDE PD 65 dysrhythmias 65 isoproterenol 65 ductal carcinomas 65 hypophosphatemia 65 gastro oesophageal reflux 65 advanced neoplasia 65 coronary stenoses 65 abacavir lamivudine 65 biologic DMARD 65 chorioamnionitis 65 sustained ventricular tachycardia 65 hematopoietic cancers 65 anterior uveitis 65 ischemic complications 65 Torsades de Pointes 65 retrograde ejaculation 65 Serious adverse reactions 65 clinically meaningful reductions 65 subclinical atherosclerosis 65 PREZISTA r arm 65 autonomic dysfunction 65 fragility fracture 65 neonatal morbidity 65 Legg Calvé Perthes disease 65 Flu Cy 65 cholecystitis 65 trimethoprim sulfamethoxazole 65 progesterone receptor negative 65 cardiac repolarization 65 rFVIIa 65 perioperative morbidity 65 nephrolithiasis 65 cerebral infarction 65 adjunctive ABILIFY 65 hypovitaminosis D 65 incidence ≥ 65 binary restenosis 65 invasive fungal infection 65 severe hypoglycaemia 65 lowest tertile 65 SRBD 65 sternal wound infections 65 CRBSI 65 hepatotoxicity 65 anagrelide 65 HbA1C levels 65 tumor histology 65 de ath 65 atopic disease 65 paroxysmal AF 65 PSA nadir 65 Pulmonary Embolism PE 65 conjunctival hyperemia 64 receiving VICTRELIS 64 venous thromboembolism 64 antiangiogenic therapy 64 posttransplant 64 NMIBC 64 AST ALT 64 coronary calcification 64 labetalol 64 endometriosis ovarian cysts 64 REYATAZ r arm 64 post surgical adhesions 64 Darapladib 64 predisposing factor 64 myocardial infarction stroke 64 hypoperfusion 64 microscopic hematuria 64 serum urate 64 lipid lowering therapies 64 alfuzosin 64 arterial stiffening 64 attain statistical significance 64 dermatologic reactions 64 HBeAg seroconversion 64 dexrazoxane 64 metachronous 64 pentoxifylline 64 SHBG levels 64 Sleep disturbances 64 serum phosphate 64 N telopeptide 64 renal flares 64 Thrombocytopenia 64 thiazide 64 gastrointestinal bleeds 64 conjugated equine estrogen 64 aspirin clopidogrel 64 REYATAZ ritonavir 64 fluvastatin 64 hyperphenylalaninemia HPA due 64 FDA defined valvulopathy 64 malperfusion 64 ATACAND 64 lipid abnormalities 64 antiandrogen 64 serum leptin 64 serum lipid levels 64 p = .# [002] 64 fatal pulmonary embolism 64 serum creatinine levels 64 eosinophil count 64 clomipramine 64 cerebrovascular accidents 64 symptom exacerbation 64 Candida infection 64 invasive ductal 64 nonadherence 64 generalized edema 64 grade cervical intraepithelial 64 distal colon cancer 64 atypical antipsychotic medications 64 serum phosphorous 64 variceal 64 hepatocellular carcinoma liver 64 vWD 64 Crohn Disease Activity 64 preoperative PSA 64 pericardial effusion 64 intraventricular hemorrhage 64 recurrent miscarriage 64 del 5q MDS 64 overt hypothyroidism 64 Nonspecific 64 lymphocytosis 64 solifenacin 64 hyperkalemia 64 node metastases 64 corticosteroid dose 64 decompensated heart failure 64 antiepileptic drugs AEDs 64 bacterial vaginosis BV 64 CIN3 64 macrovascular 64 noncardiovascular mortality 64 hepatitis C genotype 64 underwent coronary angiography 64 Aprotinin 64 poor metabolizers 64 prolactin levels 64 serum uric acid 64 tolvaptan 64 varicella infection 64 coronary revascularization procedures 64 mcg QD 64 preterm newborns 64 acromegalic patients 64 abdominal adiposity 64 QTc intervals 64 milrinone 64 atheroma volume 64 preserved ejection fraction 64 thyroid deficiency 64 silent ischemia 64 vertebral fracture 64 cardiovascular morbidity 64 hours postdose 64 x ULN 64 atherosclerotic vascular disease 64 MADRS score 64 Unstable angina 64 bolus dose 64 % CI #.#-#.# [007] 64 Primary Hypercholesterolemia 64 recurrent genital herpes 64 myocardial ischaemia 64 acute aortic dissection 64 coinfected patients 64 LVSD 64 biochemical relapse 64 lipid lowering medications 64 endophthalmitis 64 paroxetine Paxil 64 aortic stiffness 64 Y BOCS 64 arterial thrombotic 64 carotid IMT 64 interferon ribavirin 64 Exacerbations 64 virological response 64 Secondary endpoints include 64 vesicoureteral reflux 64 mycophenolate mofetil 64 patients undergoing CABG 64 argatroban 64 thrombophilia 64 decompensated cirrhosis 64 alanine aminotransferase ALT 64 knee osteoarthritis OA 64 coagulopathy 64 lipid elevations 64 liver metastasis 64 pimecrolimus cream 64 non valvular atrial 64 serum potassium 64 tumor necrosis 64 elevated bilirubin 64 repolarization 64 acute rheumatic fever 64 complete cytogenetic response 64 proliferative retinopathy 64 breast cancer recurrences 64 PCNSL 64 intracranial hypertension 64 neovascularisation 64 TDF FTC 64 troponin T 64 diabetic kidney 64 myocardial dysfunction 64 acute gout flares 64 aldosterone antagonists 64 intracerebral hemorrhage ICH 64 NPH insulin 64 premenstrual syndrome PMS 64 Non Alcoholic Fatty 64 hsCRP levels 64 OSAHS 64 plasma cortisol 64 angiographic outcomes 64 ASCUS 64 serum testosterone 64 systemic hypotension 64 cardiovascular hospitalization 64 antiplatelet therapies 64 antiemetics 64 glucocorticoid therapy 64 artery calcification 64 glycated hemoglobin HbA1c 64 asthma exacerbation 64 ICD shocks 64 nicardipine 64 paricalcitol 64 steroid dexamethasone 64 intact parathyroid hormone 64 serum IGF 64 postoperative nausea 64 IPAH 64 transaminase levels 64 abnormal lipids 64 mg BID dose 64 Hb A1C 64 iNO 64 fetal malformations 64 monoclonal gammopathy 64 recurrent preterm birth 64 hemorrhagic strokes 64 delayed CINV 64 XIENCE V PROMUS Stent 64 hepatic toxicity 64 cytogenic 64 myocardial infarctions 64 HAM D# scores 64 CHD CVD 64 GH deficiency 63 unfractionated heparin UFH 63 Fasting plasma glucose 63 abacavir Ziagen 63 G6PD deficiency 63 ischemic cardiomyopathy 63 atrial tachyarrhythmias 63 neutropenic sepsis 63 Thromboembolic 63 malignant neoplasm 63 biochemical recurrence 63 hematologic parameters 63 Prostatitis 63 EFFEXOR XR 63 menstrual abnormalities 63 neutropenia dehydration dyspnea 63 liver histology 63 primary aldosteronism 63 carotid artery thickness 63 antidiabetic medication 63 serum PSA 63 unresectable HCC 63 acute respiratory tract infections 63 liposomal amphotericin B 63 ALA PDT 63 antiandrogens 63 VLBW 63 transferrin saturation 63 benazepril 63 nasopharyngitis headache 63 LYSTEDA 63 urinary oxalate 63 overactive bladder symptoms 63 p ≤ 63 aspartate aminotransferase AST 63 metastatic GIST 63 lactate dehydrogenase LDH 63 C. difficile colitis 63 death reinfarction 63 T1DM 63 surgical prophylaxis 63 salivary flow 63 gastric varices 63 bisoprolol 63 OAB symptoms 63 GI toxicity 63 inflammatory biomarkers 63 dysuria 63 IFN beta 63 oral anticoagulation 63 rimonabant #mg 63 nadolol 63 Helicobacter pylori infection 63 intracerebral hemorrhage 63 polytherapy 63 CANCIDAS 63 transdermal estrogen 63 clinically evaluable patients 63 ß blockers 63 lumbar disk herniation 63 SGRQ 63 systolic dysfunction 63 SSRI SNRI 63 atorvastatin #mg 63 microbiological eradication 63 LOVENOX 63 dalteparin 63 paroxysmal atrial fibrillation 63 CIMZIA ™ 63 PAOD 63 carotid artery blockage 63 β blocker 63 antiarrhythmic drug 63 acarbose 63 ductal cancer 63 hemorrhagic cystitis 63 QTc interval 63 imipramine Tofranil 63 salmeterol fluticasone propionate 63 Primary endpoints 63 liver decompensation 63 postpartum haemorrhage 63 containing abacavir 63 intravenous diuretics 63 H2 blocker 63 WOMAC pain 63 BEXXAR Therapeutic Regimen 63 GnRH agonists 63 intracranial bleeding 63 antiplatelet medication 63 intensive statin therapy 63 MS relapses 63 hypoxemia 63 retinal vein occlusion 63 syncope fainting 63 CI -#.# 63 serum calcium levels 63 pyrexia mucositis sepsis febrile 63 acute asthma exacerbations 63 hematological toxicity 63 CI #.#-#.# [002] 63 gonococcal infections 63 amoxicillin clavulanate 63 maximal doses 63 fluticasone salmeterol 63 mcg dL 63 angiographic restenosis 63 neurocognitive deficits 63 protein excretion 63 ventricular remodeling 63 viral titers 63 lopinavir r arm 63 Hepatotoxicity 63 moderately emetogenic 63 chlorambucil 63 elevated transaminases 63 OGIB 63 PHPT 63 impaired glucose metabolism 63 prolactin elevation 63 leukotriene receptor antagonists 63 Ophena TM 63 unstable angina pectoris 63 neurologic outcomes 63 bullous 63 carotid artery stenosis 63 postoperative hemorrhage 63 oral allopurinol 63 eplerenone 63 treat NNT 63 Ishak fibrosis score 63 lipoprotein Lp 63 malignant neoplasms 63 febrile neutropenia 63 lipid lowering therapy 63 HPA axis suppression 63 serum lipid 63 elevated creatinine 63 phenothiazines 63 atypical ductal hyperplasia 63 ticlopidine 63 headache nasopharyngitis 63 lymphoproliferative disorder 63 PSADT 63 Skin sterol 63 CIMZIA TM certolizumab pegol 63 ARCOXIA 63 BARACLUDE ® 63 spontaneous preterm delivery 63 #.#mg/dL 63 achieved ACR# 63 A1c levels 63 divalproex sodium 63 repeat paracentesis 63 Intravenous immunoglobulin 63 nonpregnant women 63 Non inferiority 63 thrombocytosis 63 gonococcal infection 63 ug dose 63 hemodialysis patients 63 thienopyridines 63 gastric cardia 63 INFERGEN 63 nonalcoholic steatohepatitis 63 Retreatment 63 intrauterine fetal 63 prespecified secondary 63 cerebral ischemia 63 amenorrhoea 63 mL/min/#.# m 2 63 undetectable viral 63 mixed hyperlipidemia 63 nephrotoxic 63 tirofiban 63 serum BDNF 63 thyrotoxicosis 63 urinary cortisol 63 parasitemia 63 HBeAg negative patients 63 plasma folate 63 Nocturia 63 NNRTI resistance 63 HPV-#/# 63 liver transplant recipients 63 virologic failure 63 sustained virological response 63 coronary blockages 63 gonococcal 63 intracranial atherosclerosis 63 metoprolol tartrate 63 prospectively stratified 63 intra abdominal abscess 63 antithrombotics 63 albumin excretion rate 63 varices 63 Rectal cancer 63 creatinine ratio 63 hyperprolactinemia 63 titrated glipizide 63 platelet inhibition 63 Visual Analogue Scale VAS 63 orchitis 63 diabetes mellitus DM 63 interleukin IL -6 63 androgen deprivation 63 hyperalgesia 63 tachyarrhythmias 63 rhythm disturbances 63 angiographically 63 HER2 overexpression 63 chemoradiotherapy 63 distant metastasis 63 tibolone 63 autoimmune reactions 63 mammographic density 63 multivariate Cox 63 IDDM 63 gestational hypertension 63 gross hematuria 63 platelet dysfunction 63 ziconotide 63 undergone radical prostatectomy 63 severe neutropenia 63 hyperglycaemia 63 colorectal neoplasia 63 lymphopenia 63 primidone 63 oral diclofenac 63 Atherosclerotic 63 bronchial hyperresponsiveness 63 arterial stenosis 63 hyperammonemia 63 Kaplan Meier analysis 63 Aspergillus infections 63 micafungin 63 BYSTOLIC 63 HBeAg 63 postmenopausal hormone 63 microvascular complications 63 skeletal metastases 63 suboptimal adherence 63 colorectal polyp 63 symptomatic carotid stenosis 63 seminomas 63 hypertension diabetes mellitus 63 fulminant hepatic failure 63 oral antidiabetic medication 63 infective endocarditis 63 Exacerbation 63 fatal IHD 63 baseline HbA1c 63 Ischemic 63 Renal impairment 63 Tranexamic acid 63 fasting triglycerides 63 homocysteine concentrations 63 Proteinuria 63 VIIBRYD 63 nontraumatic 63 NSAID associated 63 axillary node 63 autoantibody levels 63 virologic breakthrough 63 lacunar 63 endothelial activation 63 lipid lowering agents 63 carotid plaque 63 Deep venous thrombosis 63 HBV infections 63 serum concentrations 63 intravenous heparin 63 postoperative pulmonary 63 dosing frequency 63 NUCYNTA ™ 63 QTcF 63 persistent pulmonary hypertension 63 abnormal genital 63 nonsevere 63 velafermin 63 intracerebral 63 Chlamydia infection 63 pmol L 63 lipid parameters 63 #.#/#.# mm Hg [003] 63 vitreous floaters 63 deferiprone 63 SCr 63 latent celiac disease 63 fatal myocardial infarction 63 gastrointestinal toxicity 63 HNSCC 63 p = NS 63 Subgroup analysis 63 dysplastic lesions 63 herpetic 63 decompensation 62 Hydroxyurea 62 BMPR2 62 cervicitis 62 oncologic outcomes 62 TT genotype 62 antenatal depression 62 MULTAQ 62 oxcarbazepine 62 Leukemias 62 cryptogenic 62 cisplatin gemcitabine 62 antiarrhythmic drugs 62 riociguat 62 zoledronate 62 mIU ml 62 mitochondrial toxicity 62 recurrent wheezing 62 invasive lobular 62 acute myocardial infarction MI 62 syndrome OSAS 62 perimenopausal women 62 antenatal corticosteroids 62 postmenopausal hormone replacement 62 dysfunctional voiding 62 CLA supplementation 62 metabolic acidosis 62 rizatriptan 62 DAS# CRP 62 symptomatic atrial fibrillation 62 Thal Dex 62 P = .# 62 posttreatment 62 Hip fracture 62 mechanically ventilated patients 62 serous ovarian cancer 62 infarctions 62 heparin induced thrombocytopenia 62 rt PA 62 detrusor overactivity 62 asymptomatic PAD 62 univariate analyzes 62 myeloperoxidase 62 cerebral microbleeds 62 dose atorvastatin 62 confidence intervals CIs 62 Adenomas 62 vasodilatation 62 invasive carcinomas 62 eculizumab therapy 62 macrovascular disease 62 Mitral regurgitation 62 VaD 62 Orthostatic hypotension 62 BRCA mutation carriers 62 postprandial glycemia 62 antidepressants SSRIs 62 mucosal inflammation 62 5-FU/LV 62 triiodothyronine 62 esophageal acid 62 rtPA 62 cortisol secretion 62 macrolide antibiotic 62 severe hypersensitivity reactions 62 anticoagulants blood thinners 62 Basal Cell 62 hemoglobin A1c HbA1c 62 orofacial clefts 62 vaso occlusive crisis 62 Asymptomatic 62 atrioventricular block 62 venous thromboembolism VTE 62 Abdominal aortic aneurysms 62 hydroxymethyl coenzyme 62 arterial inflammation 62 HIV seroconversion 62 epistaxis 62 seropositivity 62 Aortic stenosis 62 bone marrow suppression 62 Folfox 62 events TEAEs 62 carotid artery stenting CAS 62 nulliparous women 62 leukopenia 62 pericardial effusions 62 Hypoglycaemia

Back to home page